Medicine and Dentistry
Acute Myeloid Leukemia
100%
Acute Promyelocytic Leukemia
77%
Minimal Residual Disease
53%
Diseases
32%
Leukemia
32%
Granulocyte
27%
Real-Time Polymerase Chain Reaction
22%
Tretinoin
16%
Arsenic Trioxide
15%
NPM1
14%
Overall Survival
12%
Medical Research
12%
Karyotype
11%
Fusion Gene
10%
Anthracycline
10%
DNA Topoisomerase (ATP Hydrolysing)
8%
Treatment Response
7%
Acute Myelogenous Leukemia
7%
Targeted Therapy
7%
Cell Transplantation
7%
Hematopoietic Cell
7%
Cytarabine
6%
Hazard Ratio
6%
Mitoxantrone
6%
Morphology
6%
Molecular Diagnosis
6%
Myelodysplastic Syndrome
6%
Risk Stratification
6%
Reverse Transcription Polymerase Chain Reaction
6%
Chronic Myelogenous Leukemia
5%
Myeloproliferative Neoplasm
5%
Janus Kinase
5%
Chromosome Aberration
5%
Clinical Trial
5%
Biochemistry, Genetics and Molecular Biology
Myeloid
69%
Polymorphonuclear Cell
38%
Cytogenetics
24%
Fusion Gene
17%
Genomics
15%
Real-Time Polymerase Chain Reaction
15%
Retinoic Acid Receptor Alpha
14%
Karyotype
12%
Epigenetics
10%
DNA Gyrase
10%
Gene Expression
10%
Reverse Transcription Polymerase Chain Reaction
8%
Tretinoin
8%
Chromosomal Translocation
8%
FIP1L1
8%
PDGFRA
8%
Chromosomal Abnormalities
6%
Chimeric Protein
6%
NPM1
6%
Intron
6%
Quality Control
6%
Downregulation
5%
Janus Kinase
5%
Retinoid
5%
Morphology
5%
DNA Repair
5%
Imatinib
5%
Pharmacology, Toxicology and Pharmaceutical Science
Promyelocytic Leukemia
52%
Acute Myeloid Leukemia
51%
Minimal Residual Disease
35%
Remission
24%
Leukemia
20%
Diseases
19%
Chemotherapy
17%
Retinoic Acid
16%
Arsenite
11%
Arsenous Acid
11%
Anthracycline
8%
Chronic Myeloid Leukemia
8%
Retinoic Acid Receptor Alpha
6%
Overall Survival
6%
Myeloproliferative Neoplasm
5%
Janus Kinase
5%
Retinoid
5%
DNA Topoisomerase (ATP Hydrolysing)
5%
